Jordan VC. The development of tamoxifen for breast cancer therapy. In: Jordan VC, ed. Long-term tamoxifen treatment for breast cancer. Madison: University of Wisconsin Press, 1994:3-26.
Langan Fahey SM, Jordan VC, Fritz NF, Robinson SP, Waters D, Tormey DC. Clinical pharmacology and endocrinology of long-term tamoxifen therapy. In: Jordan VC, ed. Long-term tamoxifen treatment for breast cancer. Madison: University of Wisconsin Press, 1994:27-56.
Osborne CK, 1996, Sci Med, 3, 32
10.2165/00003495-198937040-00004
Wiebe VJ, 1992, J Clin Oncol, 10, 990, 10.1200/JCO.1992.10.6.990
Lien EA, 1991, Cancer Res, 51, 4837
Sunderland MC, 1991, J Clin Oncol, 9, 1283, 10.1200/JCO.1991.9.7.1283
10.1016/0277-5379(90)90191-U
Hull DF, 1983, Cancer Res, 43, 413
Tormey DC, 1976, Cancer Treat Rep, 60, 1451
10.1002/1097-0142(19810815)48:4<873::AID-CNCR2820480402>3.0.CO;2-1
Stewart JF, 1982, Cancer Treat Rep, 66, 1445
10.1136/bmj.295.6606.1141-b
Michalets EL, 1998, Pharmacotherapy, 18, 84, 10.1002/j.1875-9114.1998.tb03830.x
Jordan VC, 1987, Cancer Res, 47, 4517
Jordan VC, 1987, Cancer Res, 47, 624
Ravdin PM, 1988, Cancer Res, 48, 1026
10.1016/S0140-6736(97)11423-4
Arteaga CL, Osborne CK. Growth factors as mediators of estro-gen/antiestrogen action in human breast cancer cells. In: Lippman ME, Dickson RB, eds. Regulatory mechanisms in breast cancer: advances in cellular and molecular biology of breast cancer. Boston: Kluwer Academic, 1991:289-304.
10.1002/(SICI)1097-0215(19970807)72:4<608::AID-IJC10>3.0.CO;2-7
10.1016/S0300-595X(80)80038-7
Clark GM, 1997, Proc Am Soc Clin Oncol, 16, 129a
Morrow M, Schnitt SJ, Harris JR. Ductal carcinoma in situ. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996:355-68.
10.1056/NEJM197701202960307
Osborne CK, 1985, Cancer Res, 45, 584
10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U
Fisher B, 1986, J Clin Oncol, 4, 459, 10.1200/JCO.1986.4.4.459
10.1016/0277-5379(87)90154-4
10.1056/NEJM198902233200802
Kaufmann M, 1993, J Clin Oncol, 11, 454, 10.1200/JCO.1993.11.3.454
Cummings FJ, 1993, J Clin Oncol, 11, 29, 10.1200/JCO.1993.11.1.29
10.3109/02841868809091771
10.1002/1097-0142(19900115)65:2<200::AID-CNCR2820650203>3.0.CO;2-Q
10.1002/1097-0142(19890401)63:7<1257::AID-CNCR2820630705>3.0.CO;2-X
Boccardo R, 1990, J Clin Oncol, 8, 1310, 10.1200/JCO.1990.8.8.1310
Goldhirsch A, Gelber RD. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV. In: Senn H-J, Goldhirsch A, Gelber RD, Osterwalder B, eds. Adjuvant therapy of primary breast cancer. Vol. 115 of Recent results in cancer research. Berlin, Germany: Springer-Verlag, 1989:153-62.
10.3109/02841868809091772
Rivkin SE, 1994, J Clin Oncol, 12, 2078, 10.1200/JCO.1994.12.10.2078
Pritchard KI, 1997, J Clin Oncol, 15, 2302, 10.1200/JCO.1997.15.6.2302
Fisher B, 1990, J Clin Oncol, 8, 1005, 10.1200/JCO.1990.8.6.1005
1997, J Clin Oncol, 15, 1385, 10.1200/JCO.1997.15.4.1385
Albain K, 1997, Proc Am Soc Clin Oncol, 16, 128a
10.1016/S0140-6736(96)90277-9
Saez RA, Osborne CK. Hormonal treatment of advanced breast cancer. In: Kennedy BJ, ed. Breast cancer. Vol. 1 of Current clinical oncology. New York: Alan R. Liss, 1989:163-72.
Ravdin PM, 1992, J Clin Oncol, 10, 1284, 10.1200/JCO.1992.10.8.1284
Buchanan RB, 1986, J Clin Oncol, 4, 1326, 10.1200/JCO.1986.4.9.1326
Ingle JN, 1986, J Clin Oncol, 4, 178, 10.1200/JCO.1986.4.2.178
Muss HB, 1987, J Clin Oncol, 5, 1556, 10.1200/JCO.1987.5.10.1556
10.1056/NEJM198101013040104
10.1002/1097-0142(19840315)53:6<1333::AID-CNCR2820530619>3.0.CO;2-7
10.1136/bmj.283.6304.1432
10.1002/1097-0142(19800315)45:6<1322::AID-CNCR2820450609>3.0.CO;2-K
Muss HB, 1988, J Clin Oncol, 6, 1098, 10.1200/JCO.1988.6.7.1098
Muss HB, 1994, J Clin Oncol, 12, 1630, 10.1200/JCO.1994.12.8.1630
10.1002/1097-0142(19910215)67:4<886::AID-CNCR2820670405>3.0.CO;2-O
Henderson IC. Chemotherapy for advanced disease. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast diseases. Philadelphia: J.B. Lippincott, 1987:428-79.
10.1002/1097-0142(19870915)60:6<1337::AID-CNCR2820600629>3.0.CO;2-C
10.1097/00000421-198702000-00013
10.1111/j.1445-2197.1984.tb05305.x
Vercoutere AL, 1984, Arch Surg, 119, 1301, 10.1001/archsurg.1984.01390230067016
Crichlow RW, Evans DB. Cancer in the male breast. In: Ariel IM, Cleary JB, eds. Breast cancer: diagnosis & treatment. New York: McGraw-Hill, 1987:516-28.
10.1002/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#
10.1016/1040-8428(93)90008-R
10.1016/0021-9150(84)90064-9
10.1056/NEJM199203263261302
Kristensen B, 1994, J Clin Oncol, 12, 992, 10.1200/JCO.1994.12.5.992
Powles TJ, 1996, J Clin Oncol, 14, 78, 10.1200/JCO.1996.14.1.78
10.1016/S0140-6736(89)91141-0
10.2165/00002018-199716020-00003
10.1001/archinte.151.9.1842
Kaiser-Kupfer MI, 1978, Cancer Treat Rep, 62, 315
10.1016/0277-5379(89)90351-9
Nayfield SG, 1996, J Clin Oncol, 14, 1018, 10.1200/JCO.1996.14.3.1018
10.1016/S0002-9394(99)80190-1
Tamoxifen-associated eye toxicity. Bethesda, Md.: National Cancer Institute, January 27, 1997 (memorandum).
Pritchard KI, 1996, J Clin Oncol, 14, 2731, 10.1200/JCO.1996.14.10.2731
Levine MN, 1997, Thromb Haemost, 78, 133, 10.1055/s-0038-1657515
Hard GC, 1993, Cancer Res, 53, 4534
10.1016/0959-8049(94)00349-A
10.1016/0020-7292(95)02387-R
Hann LE, 1997, AJR Am J Roentgenol, 168, 657, 10.2214/ajr.168.3.9057510
10.1016/S0002-9378(96)70386-1
